RT Book, Section A1 Almannai, Mohammed A1 Lalani, Seema R. A2 Kline, Mark W. SR Print(0) ID 1182930731 T1 Approach to a Newborn with Birth Defects T2 Rudolph's Pediatrics, 23e YR 2018 FD 2018 PB McGraw-Hill Education PP New York, NY SN 9781259588594 LK accesspediatrics.mhmedical.com/content.aspx?aid=1182930731 RD 2024/04/20 AB Congenital anomalies occur frequently and are estimated to be present in about 13% of all admissions to neonatal intensive care units in the developed countries. Data from large studies indicate that the burden of genetic diseases in neonates with congenital anomalies in intensive care settings is approximately 5% to 7%. Congenital anomalies are a leading cause of infant mortality in the United States, accounting for about 20% of all infant deaths. There are over 4500 Mendelian disorders that have a known genetic etiology at present, and a significant fraction of these present in the neonatal period. With the rapid advancement in diagnostic technologies and our increasing ability to decipher the genetic basis of birth defects, a substantial influence of genetic perturbation is recognized in infants with birth defects. Recognition of chromosomal syndromes, genomic disorders, and single-gene Mendelian diseases, as well as imprinting diseases presenting in the newborns, is paramount in this age of rapidly advancing diagnostic and treatment alternatives. While trisomy 21 (Down syndrome) remains the most common genetic condition associated with birth defects, with an estimated incidence of 1 in 700 live births, other genetic disorders play a correspondingly significant role and should be recognized by astute clinicians. Teratogens, such as warfarin, alcohol, maternal phenylketonuria, retinoic acid, and Zika virus have an important role in causing birth anomalies and should be distinguished from inherited genetic determinants. Approaching a newborn with birth defects not only requires a comprehensive evaluation to identify the underlying cause, but also involves elucidating the genetic variants in at-risk families to prevent recurrence of often serious and life-threatening congenital anomalies.